General
Cuban COVID-19 vaccine maker announces jab candidate showing 92 per cent efficacy
Cuba’s Abdala coronavirus candidate vaccine shows more than 92 per cent efficacy after three doses, its maker says.
Key points:
- Cuba is developing five vaccines, including two that are already being rolled out to the population
- The BioCubaFarma laboratory says the Abdala vaccine is 92.28 per…
Continue Reading
